N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one

C163H165N59O4 — CID 159651824

About N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one

N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one (PubChem CID 159651824) has the molecular formula C163H165N59O4 and a molecular weight of 3014.52 g/mol. Its IUPAC name is N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one.

Molecular Properties

• Compound Name: N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one
• PubChem CID: 159651824
• Molecular Formula: C163H165N59O4
• Molecular Weight: 3014.52 g/mol
• Exact Mass: 3012.45
• IUPAC Name: N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one
• SMILES: C=C(CCCNc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12)OC.CC(C)CC1CC(=O)N(c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)C1.Cc1cc(Cn2ncc3c(Nc4n[nH]c5cccnc45)cccc32)no1.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(N2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1ncc2c(Nc3n[nH]c4cccnc34)cccc21.c1cnc2c(Nc3cccc4c3cnn4CC3CCC3)n[nH]c2c1
• InChI: InChI=1S/C22H23N7O.C22H25N7O.C20H23N7O.C19H21N7.C18H15N7O.C18H18N6.2C15H14N6.C14H12N6/c1-22(13-5-6-13)11-18(30)29(12-22)21-15-8-7-14(10-17(15)28(2)27-21)24-20-19-16(25-26-20)4-3-9-23-19;1-13(2)9-14-10-19(30)29(12-14)22-16-7-6-15(11-18(16)28(3)27-22)24-21-20-17(25-26-21)5-4-8-23-20;1-13(28-3)6-4-11-22-19-15-9-8-14(12-17(15)27(2)26-19)23-20-18-16(24-25-20)7-5-10-21-18;1-25-16-12-13(21-18-17-15(22-23-18)6-5-9-20-17)7-8-14(16)19(24-25)26-10-3-2-4-11-26;1-11-8-12(24-26-11)10-25-16-6-2-4-14(13(16)9-20-25)21-18-17-15(22-23-18)5-3-7-19-17;1-4-12(5-1)11-24-16-8-2-6-14(13(16)10-20-24)21-18-17-15(22-23-18)7-3-9-19-17;2*1-9-11-6-5-10(8-13(11)21(2)20-9)17-15-14-12(18-19-15)4-3-7-16-14;1-20-12-6-2-4-10(9(12)8-16-20)17-14-13-11(18-19-14)5-3-7-15-13/h3-4,7-10,13H,5-6,11-12H2,1-2H3,(H2,24,25,26);4-8,11,13-14H,9-10,12H2,1-3H3,(H2,24,25,26);5,7-10,12H,1,4,6,11H2,2-3H3,(H,22,26)(H2,23,24,25);5-9,12H,2-4,10-11H2,1H3,(H2,21,22,23);2-9H,10H2,1H3,(H2,21,22,23);2-3,6-10,12H,1,4-5,11H2,(H2,21,22,23);2*3-8H,1-2H3,(H2,17,18,19);2-8H,1H3,(H2,17,18,19)
• InChIKey: MRQZJUGATFFBKM-UHFFFAOYSA-N
• XLogP: 30.88
• TPSA: 733.93 Ų
• H-Bond Donors: 19
• H-Bond Acceptors: 52
• Rotatable Bonds: 34
• Heavy Atoms: 226
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3014.52
LogP ≤ 5	30.88
H-Bond Donors ≤ 5	19
H-Bond Acceptors ≤ 10	52

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?

The IUPAC name of N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one (CID 159651824) is N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one.

What is the SMILES notation for N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?

The canonical SMILES for N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one is C=C(CCCNc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12)OC.CC(C)CC1CC(=O)N(c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)C1.Cc1cc(Cn2ncc3c(Nc4n[nH]c5cccnc45)cccc32)no1.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1nc(N2CC(C)(C3CC3)CC2=O)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(N2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1ncc2c(Nc3n[nH]c4cccnc34)cccc21.c1cnc2c(Nc3cccc4c3cnn4CC3CCC3)n[nH]c2c1.

What is the InChIKey of N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?

The InChIKey is MRQZJUGATFFBKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N7O.C22H25N7O.C20H23N7O.C19H21N7.C18H15N7O.C18H18N6.2C15H14N6.C14H12N6/c1-22(13-5-6-13)11-18(30)29(12-22)21-15-8-7-14(10-17(15)28(2)27-21)24-20-19-16(25-26-20)4-3-9-23-19;1-13(2)9-14-10-19(30)29(12-14)22-16-7-6-15(11-18(16)28(3)27-22)24-21-20-17(25-26-21)5-4-8-23-20;1-13(28-3)6-4-11-22-19-15-9-8-14(12-17(15)27(2)26-19)23-20-18-16(24-25-20)7-5-10-21-18;1-25-16-12-13(21-18-17-15(22-23-18)6-5-9-20-17)7-8-14(16)19(24-25)26-10-3-2-4-11-26;1-11-8-12(24-26-11)10-25-16-6-2-4-14(13(16)9-20-25)21-18-17-15(22-23-18)5-3-7-19-17;1-4-12(5-1)11-24-16-8-2-6-14(13(16)10-20-24)21-18-17-15(22-23-18)7-3-9-19-17;2*1-9-11-6-5-10(8-13(11)21(2)20-9)17-15-14-12(18-19-15)4-3-7-16-14;1-20-12-6-2-4-10(9(12)8-16-20)17-14-13-11(18-19-14)5-3-7-15-13/h3-4,7-10,13H,5-6,11-12H2,1-2H3,(H2,24,25,26);4-8,11,13-14H,9-10,12H2,1-3H3,(H2,24,25,26);5,7-10,12H,1,4,6,11H2,2-3H3,(H,22,26)(H2,23,24,25);5-9,12H,2-4,10-11H2,1H3,(H2,21,22,23);2-9H,10H2,1H3,(H2,21,22,23);2-3,6-10,12H,1,4-5,11H2,(H2,21,22,23);2*3-8H,1-2H3,(H2,17,18,19);2-8H,1H3,(H2,17,18,19).

What are the key properties of N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one?

N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one has a molecular weight of 3014.52 g/mol, XLogP of 30.88, 34 rotatable bonds, 19 hydrogen bond donors, and 52 hydrogen bond acceptors.

Where does this data come from?

All data for N-[1-(cyclobutylmethyl)indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;4-cyclopropyl-4-methyl-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;bis(N-(1,3-dimethylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine);3-N-(4-methoxypent-4-enyl)-1-methyl-6-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)indazole-3,6-diamine;N-(1-methylindazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-[(5-methyl-1,2-oxazol-3-yl)methyl]indazol-4-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-piperidin-1-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;4-(2-methylpropyl)-1-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one is sourced from PubChem (CID 159651824), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).